Pre-Filled Syringes Congregation 2013

Venue: Hilton London Euston Hotel

Location: London UK, UK, United Kingdom

Event Date/Time: Jun 25, 2013 / 8:30 am - (GMT +5:30 hours) End Date/Time: Jun 26, 2013 / 4:30 pm - (GMT +5:30 hours)
Report as Spam

Description

Pre-Filled Syringes Congregation 2013 To be held on 25th-26th June 2013 at Hilton London Euston, London, UK    The drug delivery and packaging industries are rapidly expanding, with pre-filled syringes alone predicted to exceed $4.0bn by 2015. Pre-filled syringes constitutes one of the fastest growing markets in the drug delivery and packaging sectors with total revenues in this market expected to reach $5.5bn in 20251. It continues to offer one of the highest growth potentials in the pharmaceutical industry with 20% CAGR over the past 5 years. This is driven by a marked rise in the success of biological drugs and vaccines market, which requires the drug to be injected directly into the bloodstream.    This helps facilitate absorption compared to oral delivery, which results in the drug being degraded in the stomach or metabolized by the liver before it is circulated systemically. It's difficult to reproduce these benefits with other drug delivery systems so it is unlikely to be replaced anytime soon. With the prospect of easier administration, reduced risk of detrimental occurrences and cost-effectiveness, its no wonder Pre-filled syringes Market are fast becoming the drug delivery system of choice. The continued focus of the pharmaceutical industry on biologics will mean there will be continued demand for this delivery method into the future. Pre-Filled Syringes 2013 will look at key areas including device development and the design concept; secondary packaging and quality assurance; site design and regulation and will deliver vital advice on how to create strategies for future commercial success. Delivering an in-depth market overview, whilst delivering perceptive looks into regulatory considerations, formulations and sterilization    KEY THEMES DISCUSSED AT THIS SUMMIT:-    How should the industry approach the rapidly emerging and developing pre-filled syringes?  How are policy makers shaping the contours of pre-filled syringes, and what implications they have for current biologic drug development and patent protection?  Discover new developments in the technology used to make pre-filled syringes  Commercial challenges and opportunities - strategies to develop pre-filled syringes  Opportunities for outsourcing of pre-filled syringes, challenges faced and cost effectiveness  Learn to implement best practices through recent successful strategies and business models – real time case studies  Learning the latest novel technologies in filling, closing and secondary packaging  Analysing all phases of facility design and understand the requirements of pre-filled syringes development lines  Primary container developments - Glass Vs Plastic  Risks in terms of filling techniques - volume, viscosity, foaming, trapped air in the syringe  Ascertaining the volume and level of safety that will be required to prove patient safety and efficacy to facilitate approval  Inspection technologies are available to ensure validity and quality of pre-filled syringes to ensure safety and regulatory compliance  Understanding the current regulatory and commercialisation considerations for Pre-Filled Syringes 2013 in Europe and the US  Be part of a major networking opportunity    WHO SHOULD ATTEND:-    Presidents, Chief Executives, Chief Scientific Officers, Chief Operating Officers, Senior Vice Presidents, Vice Presidents, Heads, Senior Directors, Directors, Clinicians, Principal Scientists, Principal Investigators, Managers, Project/Team Leaders:    Parenteral drug delivery, Drug Delivery, Vaccines, Packaging, Devices, Labelling, Manufacturing, Sterilisation, Sterile process systems, Technical support, Pharmaceutical formulation, Product design, Research and development, Drug discovery and delivery, Drug product process development, Drug device process development, Drug device safety, Regulatory affairs, Quality assurance, Quality control, Supply chain and procurement, Business development, Strategic alliances,Clinical product resourcing, Contract management, Investment and venture capital    For more information kindly visit : http://www.companyprofilesandconferences.com/seminars-conferences/Conference-c42/Pre-Filled-Syringes-Congregation-2013.html                                Or    Contact us at :    Company Profiles And Conferences  Phone: +919223375060 / 919223767111  Fax: +91 22 27810778  Email : info@companyprofilesandconferences.com  Website : www.companyprofilesandconferences.com/    

Venue

Hilton London Euston Hotel
London UK
UK
United Kingdom
MORE INFO ON THIS VENUE

Conference Speakers

Key Speakers:- Andrew Feilden, Chemistry Operations Director, Smithers Rapra (Former Senior Scientist, AstraZeneca ) Vikas Jaitely, Pharmaceutical Assesor, MHRA Gyorgy Zorenyi, Senior Global Safety Physician, AstraZeneca Lothar Habel, Study Director Parenterals / Injectables, Toxikon Janice Kite, Traceability Director Healthcare, GS1 Global Office Brij Patel, CEO, RegExcelconsulting (Former Biological Assessor,  MHRA ) Shotaro Suzuki, Assistant Manager, Sales & Marketing of Cyclo Olefin Polymers (COP), Zeon Corporation (Japan) Mustafa A. Zaman, Senior Consultant, Parexel Consulting Stephen Wilkins, Secretary General, Child Safe Packaging Group Matthew Young, CTO, Oval Medical Technologies Benoit Verjans, Scientific Advisor, Aseptic Technologies Chris Holloway, Group Director of Regulatory Affairs, ERA Consulting Alexander Denoon, Director & Partner, Lawford Davies Denoon Lincoln Tsang, Partner, Arnold & Porter

Exhibits included

Pre-Filled Syringes Congregation 2013 To be held on 25th-26th June 2013 at Hilton London Euston, London, UK    The drug delivery and packaging industries are rapidly expanding, with pre-filled syringes alone predicted to exceed $4.0bn by 2015. Pre-filled syringes constitutes one of the fastest growing markets in the drug delivery and packaging sectors with total revenues in this market expected to reach $5.5bn in 20251. It continues to offer one of the highest growth potentials in the pharmaceutical industry with 20% CAGR over the past 5 years. This is driven by a marked rise in the success of biological drugs and vaccines market, which requires the drug to be injected directly into the bloodstream.    This helps facilitate absorption compared to oral delivery, which results in the drug being degraded in the stomach or metabolized by the liver before it is circulated systemically. It's difficult to reproduce these benefits with other drug delivery systems so it is unlikely to be replaced anytime soon. With the prospect of easier administration, reduced risk of detrimental occurrences and cost-effectiveness, its no wonder Pre-filled syringes Market are fast becoming the drug delivery system of choice. The continued focus of the pharmaceutical industry on biologics will mean there will be continued demand for this delivery method into the future. Pre-Filled Syringes 2013 will look at key areas including device development and the design concept; secondary packaging and quality assurance; site design and regulation and will deliver vital advice on how to create strategies for future commercial success. Delivering an in-depth market overview, whilst delivering perceptive looks into regulatory considerations, formulations and sterilization    KEY THEMES DISCUSSED AT THIS SUMMIT:-    How should the industry approach the rapidly emerging and developing pre-filled syringes?  How are policy makers shaping the contours of pre-filled syringes, and what implications they have for current biologic drug development and patent protection?  Discover new developments in the technology used to make pre-filled syringes  Commercial challenges and opportunities - strategies to develop pre-filled syringes  Opportunities for outsourcing of pre-filled syringes, challenges faced and cost effectiveness  Learn to implement best practices through recent successful strategies and business models – real time case studies  Learning the latest novel technologies in filling, closing and secondary packaging  Analysing all phases of facility design and understand the requirements of pre-filled syringes development lines  Primary container developments - Glass Vs Plastic  Risks in terms of filling techniques - volume, viscosity, foaming, trapped air in the syringe  Ascertaining the volume and level of safety that will be required to prove patient safety and efficacy to facilitate approval  Inspection technologies are available to ensure validity and quality of pre-filled syringes to ensure safety and regulatory compliance  Understanding the current regulatory and commercialisation considerations for Pre-Filled Syringes 2013 in Europe and the US  Be part of a major networking opportunity    WHO SHOULD ATTEND:-    Presidents, Chief Executives, Chief Scientific Officers, Chief Operating Officers, Senior Vice Presidents, Vice Presidents, Heads, Senior Directors, Directors, Clinicians, Principal Scientists, Principal Investigators, Managers, Project/Team Leaders:    Parenteral drug delivery, Drug Delivery, Vaccines, Packaging, Devices, Labelling, Manufacturing, Sterilisation, Sterile process systems, Technical support, Pharmaceutical formulation, Product design, Research and development, Drug discovery and delivery, Drug product process development, Drug device process development, Drug device safety, Regulatory affairs, Quality assurance, Quality control, Supply chain and procurement, Business development, Strategic alliances,Clinical product resourcing, Contract management, Investment and venture capital    For more information kindly visit : http://www.companyprofilesandconferences.com/seminars-conferences/Conference-c42/Pre-Filled-Syringes-Congregation-2013.html                                Or    Contact us at :    Company Profiles And Conferences  Phone: +919223375060 / 919223767111  Fax: +91 22 27810778  Email : info@companyprofilesandconferences.com  Website : www.companyprofilesandconferences.com/